RenovoRx Announces $10.9 Million Public Offering of Common Stock
RenovoRx, Inc. (NASDAQ: RNXT) recently announced the execution of an underwriting agreement with Titan Partners Group LLC for a firm commitment underwritten public offering of its common stock. The Offering, scheduled to close on or about February 10, 2025, involves the sale of 11,523,810 shares of common stock at a public offering price of $1.05 […]
